Introduction Cigarette smoke can directly contribute to the development of skeletal muscle dysfunction. Mitochondrial oxidative capacity, a product of energy production efficiency and oxygen consumption, is important for skeletal muscle health. Whether mitochondrial energy production efficiency and muscle oxygen consumption play a role into skeletal muscle dysfunction in smokers has yet to be investigated. Thus, this study sought to test the hypothesis that mitochondrial oxidative capacity and mitochondrial efficiency are reduced in smokers compared to non-smokers. Methods 30 active smokers (Age: 33 ± 4 yrs, BMI: 30.8 ± 11.7 kg/m2) and 30 demographically matched healthy controls (Age: 33 ± 3 yrs, BMI: 32.5 ± 9.1 kg/m2) participated in this study. Participants self-reported the number of cigarettes smoked per day in the past 30 days. Near infrared spectroscopy (NIRS) was used to assess changes in oxygenated (O2Hb) and deoxygenated (HHb) hemoglobin/myoglobin of the gastrocnemius following 15s of electrical stimulation and multiple rapid arterial occlusions. The phosphocreatine (PCr) recovery rate constant (kPCr), an index of mitochondrial oxidative capacity, was calculated by fitting post-stimulation measurements to a monoexponential curve. Muscle oxygen consumption (mVO2 = abs[([ΔO2Hb – Δ HHb]/2] × 60)/(10 × 1.04) x4] × 22.4/1000) was calculated for each occlusion and the slopes of the total hemoglobin (tHb = O2Hb+HHb) signal following each occlusion were converted to muscle blood flow [mBF = 1/hemoglobin (mmol/L) × ΔtHb/Δtime]. Mitochondrial efficiency (MEFF) was calculated by the dividing the estimated mVO2 needed to achieve kPcr at 100% (mVO2estimated) efficiency by the observed mVO2 [Meff = (mVO2estimated/mVO2observed) × 100]. Results The average cigarettes smoked was 5 ± 3 cigarettes per day. kPcr was significantly (p = 0.022) reduced in smokers (1.99 ± 0.19 min-1) compared to non-smokers (2.54 ± 0.19 min-1). Compared to non-smokers (157.2 ± 45.5%), MEFF was significantly (p = 0.025) attenuated in smokers (46.5 ± 10.1%) and significantly associated with mVO2 (r = -0.409, p = 0.009) and kPcr (r = 0.461, p =0.003). Average mVO2 (p = 0.231) and mBF (p = 0.993)were not significantly different in smokers compared to non-smokers. Conclusion Muscle mitochondrial oxidative capacity and mitochondrial efficiency are reduced in smokers compared to non-smokers. However, skeletal muscle blood flow and oxygen consumption were not different between groups. Taken together, mitochondrial oxidative capacity may be reduced prior to alterations in blood flow and oxygen consumption or delivery in young smokers.
Read full abstract